Lapatinib Overview

Encyclopedia: Lapatinib

Wikipedia.orgWIKIPEDIA.ORG

Lapatinib or lapatinib ditosylate , also known as GW572016, is an anti-cancer drug developed by GlaxoSmithKline as a treatment for solid tumours such as breast and lung cancer. It was approved by the FDA on March 13, 2007, for use in patients with advanced metastatic breast cancer in conjunction with the chemotherapy drug capecitabine . It is marketed by GSK in the U.S. as Tykerb. Once regulatory approval has been...


Keep reading...

Forum Search

OmgiliOMGILI

  • Lapatinib - 7 replies

    Hi everyone, Well hopefully I will be on the Lapatinib trial from tomorrow, is there anyone Marie, I don't personally know anyone who has tried Tykerb (lapatinib) but the research...

    Nov 27, 2006

  • Landmark Tykerb(R) (Lapatinib) Data Published in the New England Journal... - 5 replies

    A new story entry has been added: Landmark Tykerb(R) (Lapatinib) Data Published in the New England "] Landmark Tykerb(R) (Lapatinib) Data Published in the New England Journal of Medicine[/URL]]: Landmark

    Dec 21, 2007

  • New Type Of Drug Shrinks Primary Breast Cancer Tumors Significantly... - 2 replies

    lapatinib could decrease tumour-causing breast cancer stem cells in the primary breast cancers of women HER-2 was over-expressed. The patients received lapatinib for six weeks, followed by a combination

    Apr 20, 2008

Doctor-moderated Forums

MedHelpMEDHELP


Related in the Kosmos


RightHealth Marketplace

RightHealthRIGHTHEALTH

  • Tykerb 250mg

    Price: $2402.74

    Lapatinib is a small molecule and a member of the 4-anilinoquinazoline class of kinase inhibitors. It is present as the monohydrate of the ditosylate...


Treatment Success for Herceptin

DailyStrengthDAILYSTRENGTH

Herceptin is a popular treatment for Lapatinib.


Condition Members Success
Breast Cancer 20 90%
Depression - Teen... 1 100%

Overall, 95% (21 members) find Herceptin helpful.